RGNX REGENXBIO Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $505.2M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $53.9K |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $913.7K |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $69.6K |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $886.0K |
| 2024-Q1 | $0 | $1.9M |
| 2024-Q2 | $0 | $510.0K |
| 2024-Q3 | $0 | $1.1M |
| 2024-Q4 | $0 | $101.1K |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $163.0K |
| 2025-Q3 | $0 | $154.0K |
| 2025-Q4 | $0 | $262.6K |
| 2026-Q1 | $0 | $53.0K |
| 2026-Q2 | $0 | $385.2K |
| 2026-Q3 | $949.4K | $501.8K |
| 2026-Q4 | $0 | $0 |
Bought$949.4K2 buy days
Sold$11.0M38 sell days
Net insider flow-$10.0Mnet selling · 5 years
Latest trade2026-08-27Ciongoli Gregory Austin
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-08-27 | Buy | Ciongoli Gregory Austin | Director | 53,407 | $9.36 | $499.7K | 1 |
| 2026-08-26 | Buy | Ciongoli Gregory Austin | Director | 49,196 | $9.14 | $449.7K | 1 |
| 2026-07-02 | Sell | PAKOLA STEVE | Other C-suite | 2,161 | $13.64 | $29.5K | 1 |
| 2026-07-01 | Sell | PAKOLA STEVE | Other C-suite | 36,725 | $12.86 | $472.3K | 1 |
| 2026-06-29 | Sell | PAKOLA STEVE | Other C-suite | 19,608 | $11.04 | $216.5K | 1 |
| 2026-05-11 | Sell | PAKOLA STEVE | Other C-suite | 15,309 | $11.02 | $168.7K | 1 |
| 2026-03-10 | Sell | PAKOLA STEVE | Other C-suite | 5,124 | $10.35 | $53.0K | 1 |
| 2025-10-09 | Sell | Simpson Curran | CEO | 20,811 | $12.62 | $262.6K | 1 |
| 2025-09-29 | Sell | Simpson Curran | CEO | 7,624 | $10.03 | $76.5K | 1 |
| 2025-09-10 | Sell | Simpson Curran | CEO | 7,734 | $10.02 | $77.5K | 1 |
| 2025-05-12 | Sell | Mills Kenneth T. | Director | 20,602 | $7.91 | $163.0K | 1 |
| 2024-10-01 | Sell | KARABELAS ARGERIS N | Director | 10,000 | $10.11 | $101.1K | 1 |
| 2024-09-03 | Sell | KARABELAS ARGERIS N | Director | 10,000 | $11.56 | $115.6K | 2 |
| 2024-08-01 | Sell | KARABELAS ARGERIS N | Director | 10,100 | $13.51 | $136.5K | 3 |
| 2024-08-01 | Sell | Simpson Curran | CEO | 100 | $15.00 | $1.5K | 1 |
| 2024-07-29 | Sell | KARABELAS ARGERIS N | Director | 11,000 | $15.05 | $165.6K | 1 |
| 2024-07-29 | Sell | Simpson Curran | CEO | 9,648 | $15.04 | $145.1K | 1 |
| 2024-07-25 | Sell | Mills Kenneth T. | Director | 15,369 | $13.96 | $214.6K | 1 |
| 2024-07-24 | Sell | Mills Kenneth T. | Director | 12,221 | $13.78 | $168.4K | 1 |
| 2024-07-17 | Sell | Mills Kenneth T. | Director | 2,210 | $13.77 | $30.4K | 1 |
| 2024-07-16 | Sell | Mills Kenneth T. | Director | 200 | $13.76 | $2.8K | 1 |
| 2024-07-01 | Sell | KARABELAS ARGERIS N | Director | 10,000 | $11.27 | $112.7K | 1 |
| 2024-05-14 | Sell | Mills Kenneth T. | CEO | 15,000 | $15.81 | $237.2K | 1 |
| 2024-04-15 | Sell | Mills Kenneth T. | CEO | 15,000 | $18.19 | $272.8K | 1 |
| 2024-03-14 | Sell | Mills Kenneth T. | CEO | 15,000 | $21.86 | $327.9K | 1 |
| 2024-03-05 | Sell | PAKOLA STEVE | Other C-suite | 12,878 | $28.36 | $365.2K | 1 |
| 2024-02-14 | Sell | Mills Kenneth T. | CEO | 15,000 | $16.75 | $251.3K | 2 |
| 2024-01-16 | Sell | Mills Kenneth T. | CEO | 45,000 | $15.18 | $683.1K | 1 |
| 2024-01-03 | Sell | PAKOLA STEVE | Other C-suite | 17,237 | $17.39 | $299.8K | 1 |
| 2023-12-19 | Sell | Mills Kenneth T. | CEO | 45,000 | $19.69 | $886.0K | 1 |
| 2023-01-03 | Sell | PAKOLA STEVE | Other C-suite | 3,138 | $22.17 | $69.6K | 1 |
| 2022-08-30 | Sell | Vasista Vittal | CFO | 2,400 | $30.24 | $72.6K | 1 |
| 2022-08-05 | Sell | Vasista Vittal | CFO | 17,280 | $35.19 | $608.1K | 1 |
| 2022-08-04 | Sell | Vasista Vittal | CFO | 400 | $35.00 | $14.0K | 1 |
| 2022-08-01 | Sell | Vasista Vittal | CFO | 2,400 | $31.26 | $75.0K | 1 |
| 2022-07-14 | Sell | Vasista Vittal | CFO | 468 | $30.00 | $14.0K | 1 |
| 2022-07-13 | Sell | Vasista Vittal | CFO | 4,332 | $30.01 | $130.0K | 1 |
| 2022-01-03 | Sell | PAKOLA STEVE | Other C-suite | 1,598 | $33.75 | $53.9K | 1 |
| 2021-12-23 | Sell | Fox Allan M. | Director | 51,231 | $35.03 | $1.8M | 2 |
| 2021-12-22 | Sell | Fox Allan M. | Director | 61,638 | $34.40 | $2.1M | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Fox Allan M. | Director | $0 | $3.9M | 2021-12-23 |
| Mills Kenneth T. | Director | $0 | $3.2M | 2025-05-12 |
| PAKOLA STEVE | Other C-suite | $0 | $1.7M | 2026-07-02 |
| Ciongoli Gregory Austin | Director | $949.4K | $0 | 2026-08-27 |
| Vasista Vittal | CFO | $0 | $913.7K | 2022-08-30 |
| KARABELAS ARGERIS N | Director | $0 | $631.4K | 2024-10-01 |
| Simpson Curran | CEO | $0 | $563.2K | 2025-10-09 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.